Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 54

1.

Current and emerging therapeutics for heparin-induced thrombocytopenia.

Cuker A.

Semin Thromb Hemost. 2012 Feb;38(1):31-7. doi: 10.1055/s-0031-1300949. Epub 2012 Feb 7. Review.

PMID:
22314601
2.

Pharmacotherapy of heparin- induced thrombocytopenia.

Dager WE, White RH.

Expert Opin Pharmacother. 2003 Jun;4(6):919-40. Review.

PMID:
12783589
3.

Heparin-induced thrombocytopenia, a prothrombotic disease.

Levy JH, Hursting MJ.

Hematol Oncol Clin North Am. 2007 Feb;21(1):65-88. Review.

PMID:
17258119
4.

Heparin-induced thrombocytopenia: present and future.

Cuker A.

J Thromb Thrombolysis. 2011 Apr;31(3):353-66. doi: 10.1007/s11239-011-0569-6. Review.

PMID:
21327506
5.

Heparin-induced thrombocytopenia: natural history, diagnosis, and management.

Deitcher SR, Carman TL.

Vasc Med. 2001;6(2):113-9. Review.

PMID:
11530963
6.

Strategies for the management of suspected heparin-induced thrombocytopenia: a cost-effectiveness analysis.

Patrick AR, Winkelmayer WC, Avorn J, Fischer MA.

Pharmacoeconomics. 2007;25(11):949-61.

PMID:
17960953
7.

Heparin-induced thrombocytopenia (an overview).

Daneschvar HL, Daw H.

Int J Clin Pract. 2007 Jan;61(1):130-7. Epub 2006 Jul 12. Review.

PMID:
16836645
8.

Heparin-induced thrombocytopenia: clinical presentations and therapeutic management.

Larned ZL, O'Shea SI, Ortel TL.

Clin Adv Hematol Oncol. 2003 Jun;1(6):356-64. Review.

PMID:
16224435
9.

Plasmapheresis and heparin reexposure as a management strategy for cardiac surgical patients with heparin-induced thrombocytopenia.

Welsby IJ, Um J, Milano CA, Ortel TL, Arepally G.

Anesth Analg. 2010 Jan 1;110(1):30-5. doi: 10.1213/ANE.0b013e3181c3c1cd. Epub 2009 Nov 21.

PMID:
19933539
10.

Delayed-onset heparin-induced thrombocytopenia type-2 during fondiparinux (Arixtra) therapy.

Modi C, Satani D, Cervellione KL, Cervantes J, Gintautas J.

Proc West Pharmacol Soc. 2009;52:5-7.

PMID:
22128408
11.

Heparin-induced thrombocytopenia: clinical manifestations and management strategies.

Menajovsky LB.

Am J Med. 2005 Aug;118 Suppl 8A:21S-30S. Review.

PMID:
16125511
12.

Reducing thrombotic complications in the perioperative setting: an update on heparin-induced thrombocytopenia.

Levy JH, Tanaka KA, Hursting MJ.

Anesth Analg. 2007 Sep;105(3):570-82. Review.

PMID:
17717208
13.

Fondaparinux as a treatment option for heparin-induced thrombocytopenia.

Papadopoulos S, Flynn JD, Lewis DA.

Pharmacotherapy. 2007 Jun;27(6):921-6. Review.

PMID:
17542773
14.

Recent advances in heparin-induced thrombocytopenia.

Cuker A.

Curr Opin Hematol. 2011 Sep;18(5):315-22. doi: 10.1097/MOH.0b013e3283497ef2. Review.

PMID:
21730833
15.

[Management of heparin-induced thrombocytopenia].

Aouizerate P, Guizard M.

Therapie. 2002 Nov-Dec;57(6):577-88. Review. French.

PMID:
12666266
16.

Heparin-induced thrombocytopenia in surgical patients.

Battistelli S, Genovese A, Gori T.

Am J Surg. 2010 Jan;199(1):43-51. doi: 10.1016/j.amjsurg.2009.01.029. Review.

PMID:
20103065
17.
18.

Heparin-induced thrombocytopenia.

Gitau MM, Arora N.

Mo Med. 2009 Jan-Feb;106(1):50-4. Review.

PMID:
19245124
19.

Pathogenesis of heparin-induced thrombocytopenia and thrombosis.

Arepally G, Cines DB.

Autoimmun Rev. 2002 May;1(3):125-32. Review.

PMID:
12849005
20.

Agents for the treatment of heparin-induced thrombocytopenia.

Warkentin TE.

Hematol Oncol Clin North Am. 2010 Aug;24(4):755-75, ix. doi: 10.1016/j.hoc.2010.05.009. Review.

PMID:
20659659

Supplemental Content

Support Center